NASDAQ : DXCM
DexCom, Inc. — Key statistics
Healthcare · Medical Devices · United States
Last price 79.93 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 30.16B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 30.69B |
| Enterprise Value | 30.27B |
Dates
| Measure | Value |
|---|
| Earnings Date | Oct 29, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 372.95M |
| Shares Outstanding | 372.95M |
| Shares Change (YoY) | -3.92% |
| Shares Change (QoQ) | -1.69% |
| Owned by Insiders (%) | 0.24% |
| Owned by Institutions (%) | 105.38% |
| Float | 371.60M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 32.27 |
| Forward PE | 27.89 |
| PS Ratio | 6.01 |
| Forward PS | 5.46 |
| PB Ratio | 12.11 |
| P/TBV Ratio | 12.77 |
| P/FCF Ratio | 27.94 |
| P/OCF Ratio | 21.70 |
| PEG Ratio | 1.33 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 30.54 |
| EV / Sales | 5.93 |
| EV / EBITDA | 20.19 |
| EV / EBIT | 24.73 |
| EV / FCF | 27.56 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.74 |
| Quick Ratio | 1.34 |
| Debt / Equity | 0.55 |
| Debt / EBITDA | 0.91 |
| Debt / FCF | 1.27 |
| Interest Coverage | 91.33 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 37.67% |
| Return on Assets (ROA) | 11.13% |
| Return on Invested Capital (ROIC) | 45.93% |
| Return on Capital Employed (ROCE) | 30.70% |
| Weighted Average Cost of Capital (WACC) | 11.87% |
| Revenue Per Employee | $459,856 |
| Profits Per Employee | $89,279 |
| Employee Count | 11,100 |
| Asset Turnover | 0.74 |
| Inventory Turnover | 2.72 |
Taxes
| Measure | Value |
|---|
| Income Tax | 271.40M |
| Effective Tax Rate | 21.50% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.48 |
| 52-Week Price Change | +20.70% |
| 50-Day Moving Average | 85.82 |
| 200-Day Moving Average | 74.56 |
| Relative Strength Index (RSI) | 47.75 |
| Average Volume (20 Days) | 4,763,714 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 15.69M |
| Short Previous Month | 14.02M |
| Short % of Shares Out | 4.21% |
| Short % of Float | 4.22% |
| Short Ratio (days to cover) | 3.91 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 5.10B |
| Gross Profit | 3.24B |
| Operating Income | 1.22B |
| Pretax Income | 1.26B |
| Net Income | 991.00M |
| EBITDA | 1.50B |
| EBIT | 1.22B |
| Earnings Per Share (EPS) | $2.55 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 1.82B |
| Total Debt | 1.39B |
| Net Cash | 425.00M |
| Net Cash Per Share | $1.14 |
| Equity (Book Value) | 2.54B |
| Book Value Per Share | 6.80 |
| Working Capital | 1.66B |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 1.41B |
| Capital Expenditures | -316.10M |
| Depreciation & Amortization | 275.00M |
| Net Borrowing | -1.21B |
| Free Cash Flow | 1.10B |
| FCF Per Share | $2.94 |
Margins
| Measure | Value |
|---|
| Gross Margin | 63.42% |
| Operating Margin | 23.98% |
| Pretax Margin | 24.73% |
| Profit Margin | 19.41% |
| EBITDA Margin | 29.36% |
| EBIT Margin | 23.98% |
| FCF Margin | 21.52% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 3.92% |
| Shareholder Yield | 3.92% |
| Earnings Yield | 3.10% |
| FCF Yield | 3.58% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $98.15 |
| Price Target Difference | 19.27% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 29 |
| Revenue Growth Forecast (3Y) | 11.26% |
| EPS Growth Forecast (3Y) | 20.70% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Jun 13, 2022 |
| Split Type | Forward |
| Split Ratio | 4:1 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 6.93 |
| Piotroski F-Score | 7 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |